Literature DB >> 7577669

Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis.

K Verschueren1, N Dewulf, M J Goumans, O Lonnoy, A Feijen, S Grimsby, K Vandi Spiegle, P ten Dijke, A Morén, P Vanscheeuwijck, C H Heldin, K Miyazono, C Mummery, J Van Den Eijnden-Van Raaij, D Huylebroeck.   

Abstract

Activins exert their effects by inducing heteromeric complexes of either of two different type I receptors, ActR-I or ActR-IB, and either of two type II receptors, ActR-II or ActR-IIB. We describe the cDNA cloning of the mouse homologue of human ActR-IB and analyze binding of radio-iodinated activin on type I/type II combinations of mouse receptors expressed from cDNA. We studied the distribution of ActR-I and ActR-IB mRNAs in postimplantation mouse embryos by in situ hybridization. In the 12.5-day postcoitum embryo, both mRNAs are found in the brain, spinal cord, some ganglia, vibrissae, lungs, body wall, stomach, gonads, ribs, limbs and shoulders. ActR-I mRNA, but not ActR-IB, is expressed in blood vessels, the heart, tongue, intervertebral discs and diaphragm. Conversely, only ActR-IB mRNA is detected in the olfactory region, eye, tooth primordium, esophagus, mesonephros, dorsal root ganglia and is strongly expressed in the spinal cord. Our results demonstrate similarities, but also differences and complementarities (mesenchymal versus epithelial expression) between the expression patterns of these type I receptors. Moreover, their expression patterns overlap with at least one of the type II activin receptors and/or one of activin subunits in some regions of the embryo, such as the brain, spinal cord, pituitary, whisker follicles, and the inner nuclear neuroblastic layer of the eye.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577669     DOI: 10.1016/0925-4773(95)00395-h

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  21 in total

1.  Activin receptor patterning of foregut organogenesis.

Authors:  S K Kim; M Hebrok; E Li; S P Oh; H Schrewe; E B Harmon; J S Lee; D A Melton
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

Review 2.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 3.  On the origin of the beta cell.

Authors:  Jennifer M Oliver-Krasinski; Doris A Stoffers
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

4.  p63 Suppresses non-epidermal lineage markers in a bone morphogenetic protein-dependent manner via repression of Smad7.

Authors:  Laura De Rosa; Dario Antonini; Giustina Ferone; Monia T Russo; Paul B Yu; Rong Han; Caterina Missero
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

Review 5.  Primary cilia in pancreatic development and disease.

Authors:  Sukanya Lodh; Elizabeth A O'Hare; Norann A Zaghloul
Journal:  Birth Defects Res C Embryo Today       Date:  2014-05-26

6.  STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma.

Authors:  Jinju Park; Woochan Lee; Sangil Yun; Saet Pyoul Kim; Kyung Hyun Kim; Jong-Il Kim; Seung-Ki Kim; Kyu-Chang Wang; Ji Yeoun Lee
Journal:  Oncol Lett       Date:  2020-06-05       Impact factor: 2.967

7.  Conditional activin receptor type 1B (Acvr1b) knockout mice reveal hair loss abnormality.

Authors:  Wanglong Qiu; Xiaojun Li; Hongyan Tang; Alicia S Huang; Andrey A Panteleyev; David M Owens; Gloria H Su
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

8.  Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors.

Authors:  Frédéric Clotman; Patrick Jacquemin; Nicolas Plumb-Rudewiez; Christophe E Pierreux; Patrick Van der Smissen; Harry C Dietz; Pierre J Courtoy; Guy G Rousseau; Frédéric P Lemaigre
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

9.  Heteromeric MAPPIT: a novel strategy to study modification-dependent protein-protein interactions in mammalian cells.

Authors:  Irma Lemmens; Sven Eyckerman; Lennart Zabeau; Dominiek Catteeuw; Els Vertenten; Kristin Verschueren; Danny Huylebroeck; Joël Vandekerckhove; Jan Tavernier
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

Review 10.  Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.

Authors:  Maurizio Pacifici; Eileen M Shore
Journal:  Cytokine Growth Factor Rev       Date:  2015-12-28       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.